IV Insulin Therapy Developer Defends Diabetes Treatment Before CMS
This article was originally published in The Gray Sheet
Executive Summary
CMS should evaluate individually the various techniques it categorizes as outpatient intravenous insulin therapy before deciding which, if any, it will cover, say two commenters to the Medicare agency